Trial
NCT06528093
A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Pancreatic Ductal Adenocarcinoma
Intervention
BI 765883
Why stopped
Primary endpoint not met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03